IRF1 and breast cancer: Moreover, according to CIDER the AP-1complex, together with the IRF1 TF, promotes the expression of RARA, linking theErbB pathway activation to the suppression of estrogen receptor activity, shown inthe more aggressive phenotypes of breast cancer.